The impact of technology on the changing practice of lung SBRT

Marianne Camille Aznar; Samantha Warren; Mischa Hoogeman; Mirjana Josipovic

doi:10.1016/j.ejmp.2017.12.020

The impact of technology on the changing practice of lung SBRT

Phys Med. 2018 Mar:47:129-138. doi: 10.1016/j.ejmp.2017.12.020. Epub 2018 Jan 10.

Authors

Marianne Camille Aznar¹, Samantha Warren², Mischa Hoogeman³, Mirjana Josipovic⁴

Affiliations

¹ Clinical Trial Service Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK; Institute for Clinical Medicine, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark; Niels Bohr Institute, Faculty of Science, University of Copenhagen, Copenhagen, Denmark. Electronic address: marianne.aznar@ndph.ox.ac.uk.
² Hall Edwards Radiotherapy Group, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
³ MC-Daniel den Hoed Cancer Center, Erasmus University, Rotterdam, Netherlands.
⁴ Niels Bohr Institute, Faculty of Science, University of Copenhagen, Copenhagen, Denmark; Department of Oncology, Section for Radiotherapy, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.

Abstract

Stereotactic body radiotherapy (SBRT) for lung tumours has been gaining wide acceptance in lung cancer. Here, we review the technological evolution of SBRT delivery in lung cancer, from the first treatments using the stereotactic body frame in the 1990's to modern developments in image guidance and motion management. Finally, we discuss the impact of current technological approaches on the requirements for quality assurance as well as future technological developments.

Keywords: Hypofractionation; Image guided radiotherapy; SABR; SBRT.

Publication types

Review

MeSH terms

Humans
Lung Neoplasms / radiotherapy*
Radiosurgery / methods*
Radiotherapy Dosage
Radiotherapy Planning, Computer-Assisted

Grants and funding

21133/CRUK_/Cancer Research UK/United Kingdom